person · Reporting owner
Reinhart Charles A. III
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OSIRIS THERAPEUTICS, INC.OSIR · Entity 158290 | Director | September 11, 2018 | September 17, 2018 |
| Pacira BioSciences, Inc.PCRX · Entity 4928 | Chief Financial Officer | June 12, 2024 | June 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OSIRIS THERAPEUTICS, INC.
Report date September 11, 2018 · Filed September 17, 2018
This filing explicitly reported no securities owned.
Pacira BioSciences, Inc.
Report date June 12, 2024 · Filed June 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,867 |
Reported balance
After 2024-06-12 transaction · row 1
1 source rowRow 1 · 2024-06-12 · Grant · Acquired 12,220 · Balance 51,867 F1: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2024 Filed Jun 13, 2024 18:14 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 12,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000081 · wk-form4_1718316843.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,867 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 17:09 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | Tax withholdingCommon Stock | 2,979 | $30.89 | $92,021.31 |
DisclosureSEC source: 0001396814-24-000054 · wk-form4_1717621778.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,647 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:38 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038028 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:38 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038028 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,626 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 07, 2023 Filed Jun 7, 2023 21:29 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 1,371 | $37.87 | $51,912.92 |
DisclosureSEC source: 0001209191-23-035261 · doc4.xml · nonDerivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,626 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 21:29 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 1,236 | $38.99 | $48,192.88 |
DisclosureSEC source: 0001209191-23-035261 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,997 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 19:41 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 19,900 | $0.00 Strike: $59.39 | $0.00 |
DisclosureSEC source: 0001209191-22-035230 · doc4.xml · derivative · entry 3 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,900 Underlying: Common Stock · 19,900 shares Expires 2032-06-08 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 19:41 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 7,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035230 · doc4.xml · nonDerivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,233 F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 19:41 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 2,516 | $61.37 | $154,416.98 |
DisclosureSEC source: 0001209191-22-035230 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,283 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:40 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040093 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:40 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040093 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,799 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:17 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 2,648 | $61.04 | $161,625.98 |
DisclosureSEC source: 0001209191-21-038891 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,799 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 18:32 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 31,500 | $0.00 Strike: $47.65 | $0.00 |
DisclosureSEC source: 0001209191-20-036050 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2030-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 18:32 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 12,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036050 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,447 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 21:07 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 1,489 | $46.33 | $68,986.86 |
DisclosureSEC source: 0001209191-20-035173 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,847 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 16:55 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 26,300 | $0.00 Strike: $43.54 | $0.00 |
DisclosureSEC source: 0001209191-19-035121 · doc4.xml · derivative · entry 3 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,300 Underlying: Common Stock · 26,300 shares Expires 2029-06-05 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 16:55 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035121 · doc4.xml · nonDerivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,336 F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2020, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 16:55 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 1,106 | $42.91 | $47,458.46 |
DisclosureSEC source: 0001209191-19-035121 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,936 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 19:19 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $38.35 | $0.00 |
DisclosureSEC source: 0001209191-18-038199 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-06-13 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 19:19 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-038199 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,042 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:08 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | SaleCommon Stock | 708 | $33.02 | $23,378.16 |
DisclosureSEC source: 0001209191-18-036182 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,042 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:04 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040679 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:04 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040679 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 20:23 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-16-154556 · doc4.xml · derivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2026-12-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.